Company Announcements

Guidance for 2022

Source: RNS
RNS Number : 6772Z
Hyundai Motor Company
26 January 2022
 

HYUNDAI MOTOR COMPANY (HMC)

Corporate Disclosure to Korea Exchange

 

 

 

Disclosure Title    :   Guidance for 2022

 

 The following is a future strategy, which may be subject to change.

1. Title of Business Plan

 Guidance for 2022

2. Details of Plan and Activity Schedule

Purpose

 Improve understanding for investors with

 disclosure of business plan for 2022

Details of Plan

 Direction and major business plan for 2022

 inclduing sales, profitability and investment.

 · Sales volume target : 4.32 Million Units

 · Sales revenue growth target (Consolidated basis) :

    13~14% level

 · Operating margin target (Consolidated basis) :

     5.5~6.5% level

· Investment plan : 9.2 trillion KRW

Proposed Schedule

From

  2022-01-01

To

2022-12-31

Expected Investment Amount (KRW)

 9.2 trillion

Expected Results

 Provide reference for investors with

 disclosure of business guidance for 2022

3. Potential Difficulties in Implementation

-

4. Date of Board Resolution (Decision Date)

 2022-01-25

5. Details of Information Released

Information Providers

 IR Team

Information Recipients

 Investors, Reporters

Date & Time of Information Released

 2022-01-25

Title and Place of Event held

 Business results annoucement for 4Q 2021

6. Contact Points

 IR Team

7. Other references useful for making investment decisions

- "Details of Plan and Activity Schedule" in #2 above may be changed depending on change in

business environment and business plan.

- "Date of Board Resolution (Decision Date)" in #4 is based on the date of providing the information.

- Related materials are available for download on IR website - IR Calender

(www.hyundai.com/worldwide)

Expected disclosure date of progress

 -

 Title and date of other disclosure related to

     this one

 2022 Business Plan (Disclosed on Jan. 4th, 2022)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEMSLMEESEDF